This examination of global market trends and the overall structure of the oncology sector sets the stage. Oncology is the pharmaceutical industry’s largest therapeutic area, representing about 18% of global prescription and over-the-counter sales in 2024. At roughly $220bn, the market is forecast to almost double by 2032, growing at 5-9% annually, according to Evaluate consensus forecasts (see Exhibit 1).
Oncology drugs not only account for a large amount of sales but also attract vast R&D investment. Over the last...
